NMT1 and malaria: NMT is now an established drugtarget for combating malaria and other infectious diseases causedby protozoan parasites,10−12 with crystal structure platformsfor structure-aided inhibitor development against Cryptosporidiumparvum,13Leishmania donovani and major,14,15 and P. vivax,16 already available.